Dear Women's Imaging Insider,
Studies have shown that in the screening setting, digital breast tomosynthesis identifies more cancers and prompts fewer false positives than 2D mammography. But how it performs in the diagnostic arena hasn't been as well-examined.
That's why a team led by Dr. Charmi Vijapura of Massachusetts General Hospital in Boston examined the technology's diagnostic performance. Vijapura presented the findings at the recent American Roentgen Ray Society (ARRS) meeting in Washington, DC. Read our Insider Exclusive to find out what she and her colleagues discovered.
When you've finished our featured article, take a look at what else is going on in the Women's Imaging Community:
- First lady Melania Trump underwent an interventional radiology procedure this week. Click here to discover why.
- Can ultrasound screen for fetal growth restriction? Learn what Vanderbilt University investigators have to say.
- Will artificial intelligence cause radiologists to overcall potential abnormalities found on mammography? Not necessarily, according to another presentation at the ARRS meeting.
- Does regular mammography screening in younger women translate into less-invasive treatment? Read about what a team from Mount Sinai Hospital in New York City found.
- Does age or density better predict interval breast cancer outcomes? The answer may surprise you, according to researchers from Massachusetts General Hospital.
- Can software perform as well as radiologists when it comes to assessing a woman's breast density? A group from the University of California, San Francisco says yes.
Finally, if you have a comment, report, or article idea to share about any aspect of women's imaging, I invite you to contact me.
